High resolution 3-D imaging reveals a dense, branching dorsal nerve network in the clitoral glans, challenging anatomical ...

In people living with HIV, the adjuvanted recombinant subunit herpes zoster vaccine shows a favorable short-term safety and ...

Firearm injuries continue to strain Texas emergency departments, with increasing hospitalizations and nearly doubled charges underscoring the growing burden on healthcare systems and communities.

FDA approval of Eli Lilly’s weight-loss pill on April 1 shows the fast-changing landscape for weight loss, obesity ...

From rabid seals off South Africa to urban Anopheles stephensi in Africa, shifting vectors and outbreaks mean clinicians must ...

Researchers say AI based body composition analysis may improve early cardiometabolic risk detection, although routine MRI ...

Recent outbreaks and cruise ship exposures are renewing the debate over whether current Andes virus precautions adequately address possible respiratory spread.

A possible first case of COVID recurrence after ensitrelvir: a vaccinated woman whose antigen levels fall and then rebound, with symptoms returning 1 day after treatment.

A 10-day course of moxifloxacin 400 mg once daily demonstrates superior efficacy to a 6-day course of azithromycin 500 mg once daily for treating Mycoplasma genitalium infection.

Two KRAS-targeted strategies are starting to reshape treatment for metastatic pancreatic cancer after decades of limited progress with chemotherapy.

Most available drugs are effective for symptom control and structural protection, but they’re not perfect and new agents are being investigated to help close the treatment gap.

FDA-approved EB therapies expand options for gene replacement and wound healing, but success depends on careful wound preparation and timing, experts say.